The term ASAH2C Activators refers to a conceptual group of chemical agents that are thought to specifically target and activate the enzyme ASAH2C. ASAH2C stands for N-acylsphingosine amidohydrolase (acid ceramidase) 2C, which is one of the enzymes involved in sphingolipid metabolism-a complex system that manages the breakdown and synthesis of sphingolipids in the cell. Sphingolipids are a class of lipids that play a crucial role in cell structure and signaling. The precise function of ASAH2C within sphingolipid metabolism is to hydrolyze ceramides into sphingosine and fatty acids, which are then utilized in various cellular processes. Activators of this particular enzyme would, therefore, be designed to enhance its activity, potentially influencing the balance and turnover of the sphingolipid components within the cell. The identification of such activators would typically involve the use of high-throughput screening assays that can measure enzyme activity in the presence of a library of chemical compounds. These assays would be sensitive to changes in the concentration of substrates or products of the enzyme-catalyzed reaction, enabling the detection of molecules that increase the catalytic efficiency of ASAH2C.
Following the initial identification phase, ASAH2C Activators would undergo a series of detailed analyses to characterize their interaction with the enzyme and the subsequent effects on its activity. This would involve kinetic studies to quantify the changes in reaction rates and determine how these compounds affect enzyme turnover and substrate affinity. Structural studies would also be integral, utilizing techniques such as X-ray crystallography or nuclear magnetic resonance (NMR) spectroscopy to elucidate the activators' binding sites and modes of action at the molecular level. Such investigations would shed light on the precise alterations in enzyme conformation and dynamics induced by activator binding. In parallel, computational approaches, including molecular docking and dynamics simulations, could provide theoretical insights into the interactions between ASAH2C and potential activators, helping to guide the rational design of more potent and selective compounds. Understanding the fundamental mechanisms by which ASAH2C Activators exert their effects would be essential for appreciating their role in the complex network of lipid metabolism and cellular signaling pathways. The exploration of these compounds would contribute significantly to the biochemical and cellular understanding of sphingolipid metabolism and the intricate molecular dance that governs lipid homeostasis within the cell.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $162.00 $316.00 $559.00 $889.00 $1693.00 | 7 | |
As a bioactive lipid, S1P can modulate gene expression through S1P receptors. | ||||||
FTY720 | 162359-56-0 | sc-202161 sc-202161A sc-202161B | 1 mg 5 mg 25 mg | $32.00 $75.00 $118.00 | 14 | |
S1P receptor modulator, could impact the sphingolipid metabolism pathway. | ||||||
Myriocin (ISP-1) | 35891-70-4 | sc-201397 | 10 mg | $106.00 | 8 | |
Inhibitor of serine palmitoyltransferase, may affect sphingolipid levels and gene expression. | ||||||
C2 Ceramide | 3102-57-6 | sc-201375 sc-201375A | 5 mg 25 mg | $77.00 $316.00 | 12 | |
A synthetic ceramide that could influence sphingolipid metabolism and related gene expression. | ||||||
Fumonisin B1 | 116355-83-0 | sc-201395 sc-201395A | 1 mg 5 mg | $117.00 $469.00 | 18 | |
Inhibits ceramide synthase, potentially influencing ASAH expression as a compensatory response. | ||||||
Desipramine hydrochloride | 58-28-6 | sc-200158 sc-200158A | 100 mg 1 g | $65.00 $115.00 | 6 | |
Known to inhibit acid ceramidase activity, could affect expression of related genes. | ||||||
GW4869 | 6823-69-4 | sc-218578 sc-218578A | 5 mg 25 mg | $199.00 $599.00 | 24 | |
Non-competitive inhibitor of neutral sphingomyelinase, could impact ASAH gene expression. | ||||||
Cyclophosphamide | 50-18-0 | sc-361165 sc-361165A sc-361165B sc-361165C | 50 mg 100 mg 500 mg 1 g | $76.00 $143.00 $469.00 $775.00 | 18 | |
Alkylating agent causing cellular stress, may indirectly influence sphingolipid metabolism-related gene expression. | ||||||
Ceranib-2 | 1402830-75-4 | sc-507503 | 10 mg | $173.00 | ||
Inhibitor of ceramidase, could lead to changes in sphingolipid metabolism and gene expression. | ||||||
β-Cyclodextrin | 7585-39-9 | sc-204430 sc-204430A | 25 g 500 g | $59.00 $527.00 | 3 | |
Modulates cholesterol and lipids, potentially affecting sphingolipid pathways and related gene expression. | ||||||